Black box labels on the medications — which are prescribed to treat menopause symptoms — warn of serious risks like breast cancer and heart attacks, which has discouraged some women from taking them.

Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting

Hormone therapy could improve quality of life for premenopausal women with gynecologic cancers who have had bilateral oophorectomy, but many OG/GYN and gynecologic oncology attendings do not feel comfortable prescribing it.

Despite the best efforts of modern medicine, Huntington’s disease is a condition that still comes with a tragic prognosis. Primarily an inherited disease, its main symptoms concern

And they feel lucky. The waitlist for treatment is three months long and growing, according to Shriti Patel, who oversees the ECT program at Norfolk General, the only hospital in Hampton Roads to offer electroconvulsive therapy. Last year, it administered 972 ECT sessions to 68 patients.

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney disease will have a new treatment.

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor Therapeutics is one step closer to bringing a speedy new weapon to the race again | CeleCor presented the results of its pivotal CeleBrate phase 3 trial in a late-breaking session at the the American Heart Association’s annual scientific sessions.

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not been established. We randomly assigned participants 45 to 85 years of